日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma

纵向液体活检可识别头颈部鳞状细胞癌免疫检查点阻断反应的早期预测性生物标志物

Wang, Binbin; Saddawi-Konefka, Robert; Clubb, Lauren M; Tang, Shiqi; Wu, Di; Mukherjee, Sumit; Sahni, Sahil; Dhruba, Saugato Rahman; Yang, Xinping; Patiyal, Sumeet; Day, Chi-Ping; Desai, Parth A; Allen, Clint; Wang, Kun; Gutkind, J Silvio; Ruppin, Eytan

FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

FXYD3 在胰腺导管腺癌中频繁表达,但不能预测生存率

Nathalie B Rasko, Christopher B Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S Samra, Anthony J Gill, Anubhav Mittal

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas

胰腺导管内乳头状黏液肿瘤引起的胰腺导管腺癌的基因表达谱分析

William A Ziaziaris, Christopher S H Lim, Loretta Sioson, Anthony J Gill, Jaswinder S Samra, Sumit Sahni, Anubhav Mittal

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy

新辅助化疗对胰腺导管腺癌基因表达谱的影响

Sumit Sahni, Christopher Nahm, Mahsa S Ahadi, Loretta Sioson, Sooin Byeon, Angela Chou, Sarah Maloney, Elizabeth Moon, Nick Pavlakis, Anthony J Gill, Jaswinder Samra, Anubhav Mittal

Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1

通过激活转移抑制因子 NDRG1 靶向 Wnt/tenascin C 介导的胰腺癌细胞和星状细胞之间的串扰

Bekesho Geleta, Faten S Tout, Syer Choon Lim, Sumit Sahni, Patric J Jansson, Minoti V Apte, Des R Richardson, Žaklina Kovačević

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy

鉴定胰腺肿瘤组织中的新型生物标志物以预测新辅助化疗的反应

Sumit Sahni, Christopher Nahm, Christoph Krisp, Mark P Molloy, Shreya Mehta, Sarah Maloney, Malinda Itchins, Nick Pavlakis, Stephen Clarke, David Chan, Anthony J Gill, Viive M Howell, Jaswinder Samra, Anubhav Mittal0

Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones

肿瘤应激源诱导两种细胞内 P 糖蛋白介导的抗性机制,这些机制可通过溶酶体靶向缩氨基硫脲来克服

Lina Al-Akra, Dong-Hun Bae, Sumit Sahni, Michael L H Huang, Kyung Chan Park, Darius J R Lane, Patric J Jansson, Des R Richardson

The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways

转移抑制因子 N-MYC 下游调节基因 1 (NDRG1) 下调 ErbB 受体家族,从而抑制下游致癌信号通路

Zaklina Kovacevic, Sharleen V Menezes, Sumit Sahni, Danuta S Kalinowski, Dong-Hun Bae, Darius J R Lane, Des R Richardson

Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)

溶酶体膜稳定性在抗增殖剂二-2-吡啶酮 4,4-二甲基-3-氨基硫脲 (Dp44mT) 的细胞毒活性中起主要作用

Elaine M Gutierrez, Nicole A Seebacher, Laila Arzuman, Zaklina Kovacevic, Darius J R Lane, Vera Richardson, Angelica M Merlot, Hiu Lok, Danuta S Kalinowski, Sumit Sahni, Patric J Jansson, Des R Richardson

Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)

二-2-吡啶酮 4,4-二甲基-3-氨基硫脲 (Dp44mT) 通过劫持溶酶体 P-糖蛋白 (Pgp) 的新机制克服多药耐药性

Patric J Jansson, Tetsuo Yamagishi, Akanksha Arvind, Nicole Seebacher, Elaine Gutierrez, Alexandra Stacy, Sanaz Maleki, Danae Sharp, Sumit Sahni, Des R Richardson